NCG
NMTC icon

Newport Capital Group’s NeuroOne Medical Technologies NMTC Stock Holding History

Newport Capital Group’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,058
Closed -$24K – 53
2022
Q3 		$24K Buy
+3,058
New +$29.1K 0.01% 62

Other funds holding NMTC

MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Newport Capital Group's NMTC Position: Q4 2022 in Review

Newport Capital Group sold out of NeuroOne Medical Technologies (NMTC) in Q4 2022, closing a stake of 3,058 shares — an estimated $24K sold.

Newport Capital Group first reported a position in NMTC in Q3 2022 and held it in 1 quarter. The position peaked at $24K in Q3 2022. 20 funds tracked by Wall St. Rank hold NMTC as of Q4 2022.

  • Newport Capital Group reported no remaining NeuroOne Medical Technologies position as of Q4 2022 after selling out during the quarter.
  • Newport Capital Group sold 3,058 NeuroOne Medical Technologies shares in Q4 2022, an estimated $24K.
  • Newport Capital Group first reported a position in NeuroOne Medical Technologies in Q3 2022 and held it in 1 quarter.
  • Newport Capital Group's NeuroOne Medical Technologies position peaked at $24K in Q3 2022.
  • 20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2022.

Based on Newport Capital Group's 13F filing for Q4 2022, filed 6 Feb 2023.